Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
TNF Inhibitors
•
ILD
•
CTD-ILD
•
Pulmonary
Do you avoid the use of TNF inhibitors in patients with RA-ILD?
If patient has mild ILD, but active joint disease could this be considered?
Related Questions
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
Is it safe to combine mycophenolate and adalimumab for management of pulmonary sarcoidosis in a patient that could not tolerate methotrexate?
How would you approach treatment of active inflammatory arthritis in a patient with MCTD (+RNP/+Chromatin) and stable ILD who has failed MMF, azathioprine and methotrexate?
Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?
How you do approach treatment for a patient with active seropositive RA (+RF/+CCP) who is receiving treatment for Hepatitis C?
Do you offer LDRT for psoriatic arthritis, rheumatoid arthritis, or polymyalgia rheumatica or fibromyalgia?
What is your approach to treating Felty syndrome in a patient with well controlled synovitis on MTX/leflunomide with persistent neutropenia/cytopenias?
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Do you prefer to taper rituximab by extending the interval between doses or decreasing the actual dose administered for RA patients who have achieved longstanding remission?
Would you have a patient temporarily discontinue methotrexate while receiving a FAST or FAST FORWARD regimen for breast irradiation?
